Global Telecom Transformers Dynamics, Trends, Revenue, Regional Segmented, Outlook & Forecast Till 2026

PUNE, INDIA, INDIA, November 26, 2020 /EINPresswire.com/ —
COVID-19 Impact on Global Telecom Transformers Market – 2020-2026

***Updated Free Sample Report Is Ready To Dispatch

Summary: Telecom Transformers Market
The report of the global Telecom Transformers Market incorporates in-depth assessment of the competitive landscape, market trends, financial analysis, product benchmarking, product market sizing, product developments, strategic analysis and so on to gauge the impact forces and impending opportunities of the market. Apart from this the report also includes learning of foremost developments in the market such as agreements, product launches, collaborations, acquisitions, mergers and so on to understand the prevailing market dynamics in current phase and its impact during the forecast period 2020-2026.

Free Sample Report PDF: COVID-19 Impact on Global Telecom Transformers Market Outlook @
https://www.wiseguyreports.com/sample-request/5726962-global-telecom-transformers-market-insights-and-forecast-to-2026?utm_medium=Jiten-18.8&utm_source=PR

Understanding the segments helps in identifying the importance of different factors that aid the
Drivers & Trends
The report of the Telecom Transformers Market also tracks the up-to-the-minute market dynamics like motivating factors, restraining factors, industry news such as mergers, acquisitions, and investments. Global Telecom Transformers Market size by value and volume-wise, market share, expansion rate based on segments such as applications, types, and combines both qualitative and quantitative methods to make micro and macro forecasts in various regions or countries. The report further can assist in comprehending the market and strategizing for business expansion, consequently. In the strategy analysis, it gives insights from marketing channel and market positioning to probable growth strategies, providing in-depth analysis for new entrants or exists competitors in the Telecom Transformers Market.
Regional Analysis
On the basis of regions, this report focuses on the status and outlook for major regions that have high consumption (sales), market share and growth rate product sales and services demand. Major regions covered in the report of the Telecom Transformers Market are Europe, North America, Asia-Pacific, Latin America, and Middle East Africa.

View Complete Report / Any Query @
https://www.wiseguyreports.com/reports/5726962-global-telecom-transformers-market-insights-and-forecast-to-2026?utm_medium=Jiten-18.8&utm_source=PR

Key Market Trends | Growth | Share | Sale | Revenue | Manufactures | Technology Component

Research Methodology
Research reports on the Telecom Transformers Market are the credible source for gaining the market reports that will provide with the lead business needs. The intention of this study is provided that a platform for many top-notch market research firms worldwide publish other research reports, as well as to help the decision-makers in finding the most suitable market research solutions under one roof. The competitive developments such as agreements, expansions, new product launches, and acquisitions in the Telecom Transformers Market are also included. This section also probes towards information on the latest mergers, acquisitions, partnerships, collaborations, and expansions occurring in the Telecom Transformers Market and allow readers to identify the best business strategies.

Top Players
The report of the Telecom Transformers Market also focuses on worldwide leading industry players providing information such as product picture, company profiles, capacity, specification, price, cost, and revenue. Upstream raw materials and equipment and downstream demand study are also carried out. With tables and figures helping analyze worldwide global Telecom Transformers Market forecast, this research provides essential statistics on the state of the industry. It is an invaluable source of guidance and direction for companies and individuals interested in the market.

What are the key segments in the market?
• By product type
• By End User/Applications
• By Technology
• By Region

Which market dynamics affect the business?
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Table of Content: Covid-19 Impact On Telecom Transformers Market

1 Study Coverage
2 Executive Summary
3 Breakdown Data by Manufacturers
4 Breakdown Data by Type
5 Breakdown Data by Application

11 Company Profiles
12 Future Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
14 Value Chain and Sales Channels Analysis
15 Research Findings and Conclusion
16 Appendix
Continued…

Download Free Sample Copy @
https://www.wiseguyreports.com/sample-request/5726962-global-telecom-transformers-market-insights-and-forecast-to-2026?utm_medium=Jiten-18.8&utm_source=PR

NOTE : Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Us:
“Wise Guy Reports Is Part of the Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Forecast Data for Industries and Governments Around the Globe. Wise Guy Reports Features an Exhaustive List of Market Research Reports from Hundreds of Publishers Worldwide. We Boast a Database Spanning Virtually Every Market Category and an Even More Comprehensive Collection of Market Research Reports Under These Categories and Sub-Categories”.

CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
Sales@Wiseguyreports.Com
Http://Www.Wiseguyreports.Com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

NORAH TRENT
Wise Guy Reports
+162 825 80070
email us here


Source: EIN Presswire

Rising Geriatric Population Results In Increased Demand For Antiglaucoma Drugs

Antiglaucoma Drugs Market Report 2020-30: Covid 19 Impact And Recovery

Antiglaucoma Drugs Global Market Report 2020-30: Covid 19 Impact And Recovery

The Business Research Company’s Antiglaucoma Drugs Market Report – Opportunities And Strategies – Global Forecast To 2030

LONDON, GREATER LONDON, UK, November 26, 2020 /EINPresswire.com/ — Avail up to 50% off on ALL research reports at: https://www.thebusinessresearchcompany.com/global-market-reports. Offer applies until Dec 31st.

Incidence of glaucoma increases with age. Due to an increase in the geriatric population worldwide, governments are launching initiatives to promote awareness on glaucoma and other eye disorders. For instance, the Vision Health initiative by Centers for Disease Control and Prevention (CDC) in the USA aimed to prevent eye disorders and improve overall eye health. In Australia, the government funded an eye screening program as part of its Vision 2020 initiative to promote awareness and prevent vision loss among the population suffering from glaucoma and other eye disorders. These government initiatives will stimulate the awareness among the people on glaucoma, driving the antiglaucoma drugs global market.

The global antiglaucoma drugs market size is expected to decline from $6.6 billion in 2019 to $5.2 billion in 2020 at a compound annual growth rate (CAGR) of -21.3%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. The COVID-19 pandemic is affecting industries across the globe, including the pharmaceutical sector. The restrictions on non-essential medical services including ophthalmology services coupled with slowed production of drugs due to extended factory closures in various countries, shortage of APIs and other chemicals, and rise in prices of key ingredients are the key factors for this decline in the antiglaucoma drugs mechanism market. The market is then expected to recover and grow at a CAGR of 5% from 2021 and reach $8 billion in 2023.

Anti-glaucoma drugs are facing the risk of patent expiration in the USA and Europe according to the antiglaucoma drugs market report. For instance, travaprost and bimatoprost, which are used in the treatment of glaucoma, will lose their patents in 2021. To get an antiglaucoma drug approved by the United States Food and Drug Administration (USFDA), the drug should have comparable intraocular pressure (IOP) lowering efficacy and benefit-to-hazard ration with respect to the benchmark drug. In 2018, Rhopressa (netarsudil) Ophthalmic Solution by Aerie Pharmaceuticals Inc., was approved by the US FDA considering its ability to lower IOP when compared to benchmarked drugs for glaucoma in the market.

Here Is A List Of Similar Reports By The Business Research Company:
Ophthalmology Drugs Market – By Type (Antiglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-market

Dry Eye Medication Market – By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/dry-eye-medication-market

Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Filgrastim Biosimilars Industry Competitors Use Strategic Collaborations For Better Innovation

Filgrastim Biosimilars Market Report 2020-30: Covid 19 Growth And Change

Filgrastim Biosimilars Global Market Report 2020-30: Covid 19 Growth And Change

The Business Research Company’s Filgrastim Biosimilars Market Report – Opportunities And Strategies – Global Forecast To 2030

LONDON, GREATER LONDON, UK, November 26, 2020 /EINPresswire.com/ — Avail up to 50% off on ALL research reports at: https://www.thebusinessresearchcompany.com/global-market-reports. Offer applies until Dec 31st.

The global filgrastim biosimilars market report is segmented by application into oncology, chronic and autoimmune diseases, blood disorders, growth hormone deficiency, infectious diseases, others, and by distribution channel into hospital pharmacy, retail pharmacy, and online pharmacy. Companies in the filgrastim biosimilar market are increasing their product innovation through strategic collaborations. To maintain position in the increasingly competitive market, companies in the filgrastim biosimilar market are developing innovative products as well as sharing skills and expertise with other companies. While companies have long collaborated with each other and with academic and research institutions in this market by way of partnerships, in- or out-licensing deals, this trend has been increasing over recent years.

Some players with major filgrastim biosimilars market shares are Cadila Pharmaceuticals, Dr. Reddy’s Laboratories, Intas Biopharmaceuticals, Sandoz, Amgen Inc., Emcure Pharmaceuticals Ltd., and Biocon.

Filgrastim biosimilar treatment is used to stimulate the bone marrow to produce more neutrophils (white blood cells) to fight infection in patients undergoing chemotherapy for cancer treatment. Only goods and services traded between entities or sold to end consumers are included. The global filgrastim biosimilars industry size reached a value of nearly $785.33 million in 2019, having increased at a compound annual growth rate (CAGR) of 12.13% since 2015. The market is expected to grow from $785.33 million in 2019 to $860.12 million in 2023 at a rate of 2.30%. The growth is mainly due to the patent expiration of filgrastim biologics and government initiatives. The filgrastim biosimilar market is expected to grow to $984.23 million in 2025 at a CAGR of 6.97% and then reach $1,279.86 million in 2030 with a CAGR of 5.39%.

Here Is A List Of Similar Reports By The Business Research Company:
Pegfilgrastim Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change
https://www.thebusinessresearchcompany.com/report/pegfilgrastim-biosimilars-global-market-report-2020-30-covid-19-growth-and-change

Oral Biologics And Biosimilars Market – By Therapeutic Mechanism (Tumor Necrosis Factor-Alpha Inhibitors, Lymphocyte Modulators, Interleukin Inhibitors, GPCR (insulin, growth hormone, parathyroid hormone) Modulators, Immunostimulants, Others), By Disease (Diabetes, Arthritis & Chron`s Disease, Cancer, Infectious Diseases, Other Autoimmune Diseases, Others Diseases), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-market

Biosimilar Hormones Global Market Report 2020-30: COVID 19 Growth and Change
https://www.thebusinessresearchcompany.com/report/biosimilar-hormones-global-market-report-2020-30-covid-19-growth-and-change

Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Study Explores Potential of Hepatitis C Drugs to Treat Coronavirus

VulcanChem – Global Leading Supplier of Research Chemicals

VulcanChem – Global Leading Supplier of Research Chemicals

Several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce. VulcanChem Update

PASADENA, CALIFORNIA, UNITED STATES, November 26, 2020 /EINPresswire.com/ — The etiological agent of coronavirus disease-19 (COVID-19) is the novel human coronavirus SARS-CoV-2, the origin of which is still being debated. Nonetheless, COVID-19 has become a pandemic of extraordinary proportions, causing worldwide disruptions in travel, economic activity, and social life. Around the world, many antiviral therapies are being investigated for the treatment of COVID-19. These drugs inhibit viral entry (via the angiotensin-converting enzyme 2 [ACE2] receptor and transmembrane serine protease 2 [TMPRSS2]), viral membrane fusion and endocytosis, or the activity of the SARS-CoV-2 3-chymotrypsin-like protease (3CLpro) and the RNA-dependent RNA polymerase.

In a recent study, experiments led by researchers at the Department of Energy's Oak Ridge National Laboratory have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce. The study, published in the journal Structure, is part of efforts to quickly develop pharmaceutical treatments for COVID-19 by repurposing existing drugs known to effectively treat other viral diseases. According to this study, hepatitis C drugs bind to and inhibit the coronavirus protease, which is an important first step in determining whether these drugs should be considered as potential repurposing candidates to treat COVID-19. The SARS-CoV-2 coronavirus spreads by expressing long chains of polyproteins that must be cut by the main protease to become functional proteins, making the protease an important drug target for researchers and drug developers.

In the study, the team looked at several well-known drug molecules for potential repurposing efforts including leupeptin, telaprevir, narlaprevir and boceprevir. Their study yielded promising results for certain hepatitis C drugs in their ability to bind and inhibit the SARS-CoV-2 main protease — particularly boceprevir and narlaprevir. Leupeptin exhibited a low binding affinity and was ruled out as a viable candidate.

The study also sheds light on a peculiar behavior of the protease's ability to change or adapt its shape according to the size and structure of the inhibitor molecule it binds to. Pockets within the protease where a drug molecule would attach are highly malleable, or flexible, and can either open or close to an extent depending on the size of the drug molecules.

The list of anti-hepatitis C compounds studied in the research and other anti-hepatitis C compounds currently available for research use can be at VulcanChem Updates.

Valerie Walters
VulcanChem
email us here


Source: EIN Presswire

Virtual Private Network Market 2020 : Applications, Market Assessments, Key Players Analysis, Share, And Forecasts 2025

PUNE, MAHARASTRA, INDIA, November 26, 2020 /EINPresswire.com/ — WiseGuyReports.Com Publish a New Market Research Report On –“ Virtual Private Network Market 2020 : Applications, Market Assessments, Key Players Analysis, Share, And Forecasts To 2025”.

Virtual Private Network Market 2020

Description: –

The global Virtual Private Network market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.8% in the forecast period of 2020 to 2025 and will expected to reach USD 2450.6 million by 2025, from USD 1625.2 million in 2019.

The Virtual Private Network market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Get a Free Sample Report of Virtual Private Network Market@ https://www.wiseguyreports.com/sample-request/5050063-global-virtual-private-network-market-2020-by-company

For more information or any query mail at sales@wiseguyreports.com

Key Players of Virtual Private Network Market are:

Cisco
IPVanish
IBM
Juniper Networks
TorGuard
Check Point Software
CyberGhost (Crossrider)
Golden Frog
Purevpn
Private Internet Access

The Virtual Private Network market report has been made post conducting a thorough analysis of ongoing trends within the industry. It offers an instant overview of the market, thus offering significant clarity regarding the market structure and the products and services associated with the same. It makes the competition level apparent in the market. Also, the report, too, offers an analytic overview of the pricing model mated with the level of challenges dealt by the manufacturers of the market. The report can be significant in terms of understanding the market dynamics having its impact on Virtual Private Network market. Overall, it offers a detailed insight into the present market state, where 2020 has been taken as the base year.

Virtual Private Network Market Driving factors and challenges

Along with the thorough knowledge of fundamental aspects of Virtual Private Network market model, it studies the trends of growth and the pricing structure, as well as the ongoing market worth. Different aspects having they're contributed towards the expansion of the market, and the challenges and opportunities can be gone through upon having a peek into Virtual Private Network market.

Virtual Private Network Market Regional Analysis

A detailed study of the Virtual Private Network market can help understand global market as per the regional details obtained. A thorough analysis of the report makes it evident where the market can remain the most concentrated and where it can be challenging.
In this context, key nations include Europe, Latin America, North America, Asia Pacific, and Middle East & Africa. Moreover, the regional analysis has been done for the concerned nations taking the ongoing trends into account and the scopes and challenges associated and thus offering a thorough outlook that could be advantageous regarding market growth.

Virtual Private Network Market Modes of Research

Keeping the concentration intact on the market's analytic details where forecasted periods are considered, the market study can be done thoroughly. Here those aspects are considered which establish Porter’s Five Force Model. Alongside this, the data analysts go through extensive SWOT analysis as per the report, offering key details about the Virtual Private Network market. Detailed analysis of the market can be helpful in figuring out and explaining the prime advantages, challenges, opportunities, weaknesses, etc.

Virtual Private Network Market Key Players Analysis

On the basis of key players, the report offers an insight into the competitive scenario of the market as well as the key players, ongoing trends witnessed within the manufacturing arena, etc. The report, at the same time, throws light into prominent vendors having significant contributions to the market.

Enquiry About Virtual Private Network Market @ https://www.wiseguyreports.com/enquiry/5050063-global-virtual-private-network-market-2020-by-company

Table of Contents – Major Key Points of Virtual Private Network Market 2020

1 Market Overview

2 Manufacturers Profiles

3 Sales, Revenue and Market Share by Manufacturer

4 Global Market Analysis by Regions

5 North America by Country

6 Europe by Country

7 Asia-Pacific by Regions

8 South America by Country

9 Middle East & Africa by Countries

10 Market Segment by Type

Continued…

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Munavvar Izhar MD Discusses Novel In Vitro Diagnostic Testing Techniques & AMINDO BIOLOGICS Ltd.

Munavvar Izhar MD

With Novel In Vitro Testing Options Being Developed, Munavvar Izhar MD Believes This Could Change How Testing Is Performed in the Medical Field.

CHICAGO, IL, UNITED STATES, November 25, 2020 /EINPresswire.com/ — Dr. Munavvar Izhar is a consultant with AMINDO BIOLOGICS Pvt. Ltd. a company with headquarters in New Delhi and with market supply all over India, neighboring Asian countries, and expanding internationally. When it comes to the field of medicine, this is a field that is based entirely on clinical acumen, information, and technology. If doctors do not have the information they need to make decisions, then they are not going to be able to make decisions that are in the best interests of their patients. Munavvar Izhar MD has been working hard to strategize new in vitro testing technique availability to patients, clinics, hospitals and diagnostic centers both in rural and urban areas. This will make it easier for doctors to make decisions on behalf of their patients. When it comes to new testing techniques, Munavvar Izhar is amalgamating and assimilating novel PCR and m-RNA messenger testing techniques. Most of these tests and panels are available for distribution through AMINDO BIOLOGICS Pvt. Ltd.(www.amindobiologics.com)

Munavvar Izhar MD Discusses the Current Laboratory Testing Techniques
When it comes to running lab tests right now, the most popular tests are largely the same as they were in the 1970 and 80s. Dr. Munavvar Izhar knows that when he was going through training, many of those tests are still run today. Patients have their blood drawn. They have their urine tested. They even have their spinal fluid tested via a lumbar puncture. The samples are sent to the labs, run on analyzers and the results are usually available next day or sometimes even after 2-3 days.

Munavvar Izhar MD Discusses the Growing Role of In Vitro Testing in the Medical Field
The field of medical diagnosis has rapidly transformed over the last 5-10 years from manual estimations and time consuming tests to quick results that are available right away or within 2-3 hours making patient care of the highest standard. This improves the standard of healthcare, especially in the developing world. This is due to the rapid advances happening in the In Vitro Diagnostic testing involving techniques like ELISA, IFA, IHC, FLOW CYTOMETRY and PCR which have revolutionized the world of diagnostic testing.

Munavvar Izhar MD Discusses the Future of the Medical Field and Novel Testing Capabilities
AMINDO BIOLOGICS intends to bring the latest state-of-the-art technologies. Dr. Munavvar Izhar, M.D. is focused on bringing innovative diagnostic solutions to customers globally. This helps physicians and patients alike to make informed and timely decisions.
AMINDO BIOLOGICS under the guidance of Dr. M. Izhar is committed to providing the best quality products and services to the customers. AMINDO BIOLOGICS offers top-quality assays and panels to enable physicians to accurately analyze and diagnose the diseases. Our aim is to offer the most reliable and innovative technologies and solutions. www.amindobiologics.com

Caroline Hunter
Web Presence, LLC
+17865519491
email us here
Visit us on social media:
LinkedIn


Source: EIN Presswire

A 30 Minute Non-Invasive Solution for Ovarian Cysts

Tucson Biofeedback, Biofeedback, Neurofeedback And Frequency Clinic in Tucson Arizona

Tucson Biofeedback, Biofeedback, Neurofeedback And Frequency Clinic in Tucson Arizona

tucson biofeedback, tucson biofeedback staff, Dr. Anna Blessing, Tucson Wellness Services

Tucson Biofeedback’s Staff

30 Minute Frequency Specific Microccurrent Treatment Provides Relief from Ovarian Cysts

30 Minute Frequency Specific Microccurrent Treatment Provides Relief from Ovarian Cysts

Non-Invasive Treatment Offers Relief from Ovarian Cysts in 30 Minutes

TUCSON, ARIZONA, USA, November 25, 2020 /EINPresswire.com/ — A remarkable newly rediscovered treatment, frequency specific microcurrent (FSM) takes advantage of the body’s ability to respond to frequencies in order to heal a number of chronic conditions.

Using a two-channel microcurrent device that have changed medicine and created new possibilities for suffering patients over the past twenty years. Nerve pain, fibromyalgia, diabetic neuropathies, muscle pain, athletic performance, injury repair, joint pain, low back pain, neck pain, kidney stone pain, the kidney stones themselves, liver disease, diabetic wounds, brain and spinal cord injuries, PTSD, depression, shingles, asthma, ovarian cysts, abdominal adhesions, and scarring all respond to specific frequencies.

If you have or do suffer from Ovarian Cysts, then you know how painful they can be. There is now a protocol and frequency pairs that reduce the ovarian cyst(s) in 30 minutes.

It incorporates what’s called “Frequency Specific Microcurrent” or FSM. 2 sets of Ads are applied to the cystic region, you are put on the Ovarian Cyst protocol and in real time you can feel the inflammation and pressure go down until it is no longer present.

This relief has occurred in 100% of applications of true Ovarian Cysts. However, to permanently resolve the issues that contribute to the cysts, those do require Lifestyle changes and addressing Histamine Intolerance all which can be done non-invasively.

Sarah who had suffered from Ovarian Cysts for years came into Tucson Biofeedback for help with migraines, hormone issues including ovarian cysts.

“I was frustrated and skeptical, but within 20 minutes of my 30 minute Ovarian Cyst protocol I experienced complete relief and release of the pressure from my cysts. I mean I was amazed, especially because I had never heard of FSM. I continued working with Tucson Biofeedback to address my Histamine Intolerance and Sensitivities as well as crating a lifestyle for me and can happily say I am cyst free.”

There is a number of great strides being made in the Wellness realms, especially with the resurgence of Frequency Therapies: Biofeedback, Neurofeedback, Microcurrent, Radionics etc. Non-Invasive therapies are taking precedence over more invasive and painful processes.

If you would like to learn more about different frequency therapies please visit the education portal here. There are a number of books and resources for you to dive into.

Dr. Anna Blessing
Tucson Biofeedback
+1 520-314-6894
email us here


Source: EIN Presswire

CALORIE REDUCED VITAFIBER® IMO ANSWERS U.S. CONSUMERS DEMAND FOR A BETTER TASTING SUGAR ALTERNATIVE

Sugar Like Taste without the Sugar

NEW SURVEY SHOWS CONSUMERS DISSATISFIED WITH AFTERTASTE OF HIGH INTENSITY SWEETENERS.

BioNeutra Global Corporation (TSX:BGA)

VitaFiber provides the right level of sweetness, has great mouthfeel (sugar-like texture) no bitter aftertaste, masks high-intensity sweeteners, bulks, binds and can be heated to 160 degrees C.”

— Sheri O'Brien, Vice President/Sales & Marketing, BioNeutra Global Corp.

NEW YORK , NEW YORK , USA, November 25, 2020 /EINPresswire.com/ — CALORIE REDUCED VITAFIBER® IMO ANSWERS U.S. CONSUMERS DEMAND FOR A BETTER TASTING SUGAR ALTERNATIVE
NEW SURVEY SHOWS CONSUMERS DISSATISFIED WITH AFTERTASTE OF HIGH INTENSITY SWEETENERS.

Taste is king with American consumers, who according to new research released today, shy away from a wide range of consumer products containing low-calorie, high-intensity sweeteners because they feel they do not measure up to sugar. Survey respondents say the sweeteners have an unsatisfactory texture and give off an aftertaste. To them, it does not have the sweet taste or texture of sugar that they’re used to.

That’s a key finding of a national attitudinal survey conducted among 529 American consumers, 18 years or over, conducted in September 2020 by Marketplace, a health and wellness marking company. The survey was done for BioNeutra North America Inc., a company that developed and manufactures a product that is popular in the food and beverage industry. Its product, VitaFiber® IMO is a lower-calorie sweetener that has a great sugar like taste and mouthfeel that consumers want; can mask the aftertaste of high-intensity sweeteners and offers a smooth texture. It also provides health benefits – something consumers seek.

For the food and beverage industry concerned with sugar reduction strategies, the survey provides valuable data on consumer attitudes towards products such ice cream, chocolates, baked goods, snacks, soda, candy, protein bars and sports drinks. Ice cream offers the industry the biggest growth opportunity because 40% of respondents said they would eat more calorie-reduced ice cream if manufacturers used alternative sweeteners that tasted and felt more like sugar. The respondents found the low-calorie sweeteners provided both an unsatisfactory taste and texture.

Consumers also indicated that sugar alternatives that require flavor masking and bulking agents to counteract a lingering aftertaste or lack of mouthfeel do not match their desire for natural and plant-based ingredients. When compared to sugar, more than half of consumers who buy low-calorie sweeteners felt they do not measure up. Nearly half of those consumers felt the sweeteners fail the taste test and simply do not taste like sugar.

Here is how they described their concerns about low-calorie sweeteners in general:

• 43.3% unnatural flavor
• 41.8% unpleasant aftertaste
• 39.4% do not have the right level of sweetness

Close to two thirds of consumers surveyed (60.59%) feared that ice cream including low-calorie sweeteners would have an unpleasant aftertaste; 57.7% expected it would disappoint them and not offer the right level of sweetness and 51.8% expressed a concern about texture. The survey confirmed that the food and beverage industry needs to change formulations and attitudinal impressions to be successful in its sugar reduction efforts.

BioNeutra’s Vice President of Sales and Marketing Sheri O’Brien says, “In our industry the senses rule. Taste and texture are critical.” She says, “We’re proud of our award-winning lead product. It’s well-suited to be a formulator’s novel ingredient because of its seven key benefits. It provides the right level of sweetness (42% of honey), has great mouthfeel (sugar-like texture) no bitter aftertaste, masks high-intensity sweeteners, bulks, binds and can be heated to 160 degrees C.”

In chocolate formulations, VitaFiber® IMO can be used as a 1 to 1 sugar replacement; its viscosity and clean taste also reduces the need for bulking agents and flavor masking when replacing sugar in candies, ice cream, soft drinks and other applications with upfront sweetness.

For more details go to: https://www.bioneutra.ca/reduced-sugar-low-calorie

About BioNeutra
BioNeutra is an award-winning, sector-leading Canadian company in the business of research and development, production and commercialization of ingredients for nutraceutical, functional and mainstream foods and beverages with a focus on its lead product – VitaFiber® IMO. BioNeutra’s goal is to improve consumer nutrition and public health.

VitaFiber® IMO is made using a patented process that naturally and enzymatically converts starch molecules from plant-based starches such as pea or tapioca into healthy functional molecules. The conversion process does not involve any chemical modification making VitaFiber a natural food and beverage ingredient. regarded as safe (GRAS) by the U.S. Food & Drug Administration; a novel food ingredient by Health Canada and the European Food Safety Authority. Additionally, Health Canada has approved VitaFiber® IMO as a dietary fiber.

Additionally, Health Canada has approved VitaFiber® IMO as a dietary fiber. VitaFiber® IMO is naturally sweet, lower in calories than sugar and a natural source of prebiotic dietary fiber for human digestive health.
VitaFiber® IMO is also non-GMO, vegan friendly, gluten-free, Kosher and Halal certified and available as certified organic.
The Company’s customers include a mix of small and medium businesses as well as a number of high- profile food and beverage manufacturers on four continents.
www.bioneutra.ca www.vitafiberimo.com www.vitafiberimo.ca
Media Contact:
Warren Michaels
Vice President/Communications BioNeutra Global Corporation
warren.michaels@bioneutra.ca Cell: +1-780-977-8261

Warren Michaels
BioNeutra Global Corporation
+1 780-977-8261
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

RAPID DOSE THERAPEUTICS SIGNS DEFINITIVE AGREEMENT TO ENABLE COMMERCIAL PRODUCTION OF ULTRAPURE THC™ DISTILLATE

BURLINGTON, ONTARIO, CANADA, November 25, 2020 /EINPresswire.com/ — RAPID DOSE THERAPEUTICS SIGNS DEFINITIVE AGREEMENT TO ENABLE COMMERCIAL PRODUCTION OF ULTRAPURE THC™ DISTILLATE USING RDT’S NOVEL CBD TO THC CONVERSION TECHNOLOGY

Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions is pleased to announce it signed a definitive agreement with ESJ Enterprises, LLC. RDT has licensed ESJ to produce Ultrapure THC (U-THC™) Delta 9 distillate using the RDT’s proprietary CBD to THC conversion technology.

Jason Lewis, RDT SVP Business Development said “Despite COVID-19 market challenges, RDT continues to demonstrate its focus on novel technological advancements. In conjunction with our licensee, we have proven the commercial capability of consistently producing Ultrapure THC Delta 9 distillate in mass quantities. THC from CBD derived from hemp is a major breakthrough in the cannabis industry. We can help manage global distillate shortages and allow consumers to benefit from an ultrapure regulated THC product.”

In conjunction with the McMaster University research team lead by Drs. James Mcnulty and Alex Nielsen, RDT has developed a process using its Genius Conversion Catalyst™ (GCC™) to transform CBD isolate into THC distillate with a selective Delta 9 or Delta 8 outcome at a rate of 99%. ESJ has worked with RDT to create a scalable process facility that can produce up to 100 kg of Ultrapure THC (U-THC™) Delta 9 distillate per day. By combining the steady supply of high-quality Isolera Extracts CBD isolate with the RDT GCC process, an unlimited amount of U-THC™ distillate is possible.
Production of the first 400 kg of U-THC™ distillate will be completed in Oklahoma prior to December 15, 2020, to fill a backlog of demand in the state. Continuous production of the Ultrapure THC will commence in Michigan in December 2020 to ensure cannabis processors there can meet their market supply requirements.
Jack Tatum, ESJ CEO, said “The combined effort of RDT and ESJ has created a unique way to solve the massive and continuous supply issues facing producers in most states. We are pleased with the working relationship and the joint focus on producing Ultrapure THC products with the intent to change the THC distillate market dynamics globally. The ESJ team has the equipment and proven experience to deliver on its contracts and quality promise and will continue to expand production.”
About Rapid Dose Therapeutics

Rapid Dose Therapeutics Corp. is a publicly-traded Canadian Life Sciences company providing innovative, proprietary drug delivery technologies designed to improve outcomes and quality of life. RDT offers Quick, Convenient, Precise, and Discreet™ choices to consumers. RDT is focused and committed to clinical research and product development for the healthcare manufacturing industry — including nutraceutical, pharmaceutical, and cannabis industries. Within the cannabis sector, RDT also provides a turn-key Managed Strip Service Program enabling RDT’s QuickStrip™ proprietary cannabis delivery technology to be licensed to select operators in identified markets. RDT’s service-based annuity contracts drive recurring revenue and facilitate rapid expansion into emerging markets across multiple consumer segments. RDT is committed to continually create innovative solutions for humans, animals, and plants.

For more information, visit: www.rapiddose.ca

For inquiries please contact:

Mark Upsdell
CEO
mupsdell@rapid-dose.com
Ofc (416) 477-1052

Pat McCarthy
Managing Director Capital Markets
pmccarthy@leedejonesgable.com
Ofc (416) 365-8012

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:
Certain information in this news release may contain forward-looking information within the meaning of applicable securities laws.
Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend”, “will”, “could”, “are planned to”, “are expected to” or the negative of these terms and similar expressions. Statements containing forward-looking information, including, without limitation, in respect of the delivery of equipment and products using the QuickStrip™ product delivery method, the generation of recurring revenues and the dismissal of the CTT lawsuit, express, as at the date of this news release, the plans, estimates, forecasts, projections, expectations or beliefs of RDT management as to future events or results and are believed to be reasonable based on information currently available to RDT management. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; termination of WLM agreements; future legislative and regulatory developments involving cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the cannabis industry in Canada generally, income tax and regulatory matters; the ability to implement its business strategies; competition; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. There can be no assurance that statements of forward-looking information, although considered reasonable by RDT management at the time of preparation, will prove to be accurate as there can be no assurance that the plans, intentions, or expectations upon which they are based will occur. Actual results and future events could differ materially from those anticipated in such forward-looking statements. Readers should not place undue reliance on forward-looking statements. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

MARK A UPSDELL
Rapid Dose Therapeutics
+1 4164771052
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Rapid Diagnostic Test (RDTs) Market 2020 Global In-Depth Investigation And Analysis Report To 2026

WiseGuyReports.Com Publish a New Market Research Report On–“Rapid Diagnostic Test (RDTs) Market 2020 Global In-Depth Investigation And Analysis Report To 2026”.

PUNE, MAHARASTRA, INDIA, November 25, 2020 /EINPresswire.com/ —

Rapid Diagnostic Test (RDTs) Market 2020

Description: –

Global Rapid Diagnostic Test (RDTs) market is highly classified by enriched products to help diverse industries grow with their business operations. The key players scattered across different regions of the globe are putting in their maximum efforts to make sure that the products can be developed at a higher pace to meet the growing needs and requirements of the consumers. As the demands are growing on a larger scale, the key players are also improvising the products along with the manufacturing infrastructure, in order to increase the production speed without compromising on the quality of the product. Hence, they are executing progressive measures to help grow the overall demand of the products listed under the global Rapid Diagnostic Test (RDTs) market.

Get a Free Sample Report of Rapid Diagnostic Test (RDTs) Market @ https://www.wiseguyreports.com/sample-request/6085148-global-rapid-diagnostic-test-rdts-market-outlook-2021

For more information or any query mail at sales@wiseguyreports.com

Key Players Included in Rapid Diagnostic Test (RDTs) Market are:

The major players in the market include Merck, GSK, Sanofi, Pfizer, Abbott, Sekisui Diagnostics, Siemens Healthcare, Autoliv, Nippon Kayaku Group, Daicel Corporation, Hirtenberger, etc.

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Digital RIDTs
Conventional RIDT

Segment by Application
Hospitals & Clinics
Laboratories
Other

There are many industries that have already accepted the efficiency of the products and are implementing it for their businesses to experience a progressive hike. As a result, the industries put their trust in the primary key players who are also reputed brands across various regions. The essential players do the promotions and even handle the sales to generate revenue for the overall global market. They make sure that the supply chain of the products under the global Rapid Diagnostic Test (RDTs) market runs seamlessly without much interruptions related to quality or shortage in stock.
Therefore, the key players keep their brand reputation intact with all the positive implementations along with the quality manufacturing of the products.
The report focuses on the global Rapid Diagnostic Test (RDTs) market strength to deal with the upcoming fluctuations. The report states the preparatory measures taken by the global Rapid Diagnostic Test (RDTs) market for upgrading the selling and promoting methods to retain the lost consumers and bring new ones as well. Along with that, the report also focuses on the regional classification that states the market strength across various regions of the globe. The market size of the global Rapid Diagnostic Test (RDTs) market in the previous forecast period was large, which was the highest of all time. But as the demand has grown stupendously in the past few years, the market size is expected to grow even higher, breaking its own record during the period 2020 to 2026.

Rapid Diagnostic Test (RDTs) Market Regional Classification 2020

Based on the geographical classification, the global Rapid Diagnostic Test (RDTs) market is widely spread across various regions that include North America, South America, Europe and Asia-Pacific. The key players across these regions are putting in their collective effort to improvise the products and contribute to enhancing the overall demand and revenue for the global Rapid Diagnostic Test (RDTs) market.

Enquiry About Rapid Diagnostic Test (RDTs) Market Report @ https://www.wiseguyreports.com/enquiry/6085148-global-rapid-diagnostic-test-rdts-market-outlook-2021

Table of Contents – Major Key Points of Rapid Diagnostic Test (RDTs) Market

1 Rapid Diagnostic Test (RDTs) Market Overview

2 Market Competition by Manufacturers

3 Production and Capacity by Region

4 Global Rapid Diagnostic Test (RDTs) Consumption by Regions

5 Rapid Diagnostic Test (RDTs) Production, Revenue, Price Trend by Type

6 Global Rapid Diagnostic Test (RDTs) Market Analysis by Application

7 Company Profiles and Key Figures in Rapid Diagnostic Test (RDTs) Business

8 Rapid Diagnostic Test (RDTs) Manufacturing Cost Analysis

9 Marketing Channel, Distributors and Customers

10 Market Dynamics

Continued…

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire